0001209191-17-059752.txt : 20171108
0001209191-17-059752.hdr.sgml : 20171108
20171108162331
ACCESSION NUMBER: 0001209191-17-059752
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171106
FILED AS OF DATE: 20171108
DATE AS OF CHANGE: 20171108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Townsend Christopher G
CENTRAL INDEX KEY: 0001555359
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15787
FILM NUMBER: 171186903
MAIL ADDRESS:
STREET 1: METLIFE
STREET 2: 200 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10166
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: METLIFE INC
CENTRAL INDEX KEY: 0001099219
STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311]
IRS NUMBER: 134075851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10166
BUSINESS PHONE: 212-578-5500
MAIL ADDRESS:
STREET 1: 200 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10166
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-06
1
0001099219
METLIFE INC
MET
0001555359
Townsend Christopher G
LEVEL 20, CITYPLAZA 3
14 TAIKOO WAN ROAD
TAIKOO SHING
K3
00000
HONG KONG
0
1
0
0
President, Asia
Common Stock
2017-11-06
4
M
0
25181
45.15
A
25181
D
Common Stock
2017-11-06
4
S
0
25181
54.343
D
0
D
Common Stock
2017-11-06
4
M
0
17425
45.91
A
17425
D
Common Stock
2017-11-06
4
S
0
17425
54.289
D
0
D
Common Stock
2017-11-06
4
M
0
13106
34.33
A
13106
D
Common Stock
2017-11-06
4
S
0
13106
54.20
D
0
D
Employee Stock Option (Right to Buy)
45.15
2017-11-06
4
M
0
25181
0.00
D
2024-02-24
Common Stock
25181
0
D
Employee Stock Option (Right to Buy)
45.91
2017-11-06
4
M
0
17425
0.00
D
2025-02-23
Common Stock
17425
8713
D
Employee Stock Option (Right to Buy)
34.33
2017-11-06
4
M
0
13106
0.00
D
2026-02-22
Common Stock
13106
26216
D
The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4.
The shares were sold in multiple transactions at prices $54.131 to $54.490, inclusive.
The shares were sold in multiple transactions at prices $54.225 to $54.370, inclusive.
The shares were sold in multiple transactions at prices $54.061 to $54.325, inclusive.
The options became exercisable in three equal installments on February 25, 2015, 2016 and 2017.
The options became exercisable in three equal installments on February 24, 2016, 2017 and 2018.
The options became exercisable in three equal installments on February 23, 2017, 2018 and 2019.
Mark A. Schuman, authorized signer
2017-11-08